Filing Flows › Colgate Palmolive (CL) › Q3 2025
Colgate Palmolive (CL) Q3 2025 earnings results (third quarter 2025)
10-Q filed Oct 31, 2025
Colgate Palmolive (CL) reported revenue of $5.1B for the third quarter 2025 (Q3 2025), +2% from a year earlier and +0.4% from the quarter before. Operating margin was 20.6%, net earnings $735M (14.3% of revenue).
Colgate Palmolive, Q3 2025: revenue $5.1B (+2% year over year), operating margin 20.6%, net earnings $735M, operating cash flow $1.3B. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.1B | +0.4% | +2% |
| Gross profit | $3.0B | -0.7% | -0.8% |
| Operating profit | $1.1B | -2% | -0.6% |
| Net earnings | $735M | -1% | -0.3% |
| Operating cash flow | $1.3B | +43% | +8% |
| Free cash flow | $1.1B | +43% | +7% |
What changed
Revenue was $5.1B in Q3 2025, up 2% year over year and roughly flat from the previous quarter.
Gross margin was 59.4%, down 1.7 points from a year earlier. Operating profit was $1.1B, a 20.6% margin (down 0.5 points year over year). Operating profit fell $0.01B even though revenue rose $0.10B versus a year earlier, so costs grew faster than sales. Operating expenses fell 1% while revenue rose 2%. Net earnings were $0.73B, roughly flat year over year. The effective tax rate was 22.8%.
Operating cash flow was $1.3B (up 8% year over year), 165% of net income including minority interests. Non-cash charges added back $0.16B of depreciation and amortization and $0.07B of share-based compensation. Working capital and other items added $0.27B. Capital expenditures of $0.15B left free cash flow of $1.1B.
Questions
What was Colgate Palmolive's revenue in the third quarter 2025?
Colgate Palmolive (CL) reported revenue of $5.1B for the third quarter 2025 (Q3 2025), +2% from a year earlier and +0.4% from the quarter before.
Was Colgate Palmolive profitable in the third quarter 2025?
Operating profit was $1.1B (20.6% of revenue) and net earnings $735M.
Source: Colgate Palmolive 10-Q on SEC EDGAR.